Omalizumab (rch) (other respiratory medicines and devices)

Omalizumab (rch) (other respiratory medicines and devices) is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about omalizumab (rch) (other respiratory medicines and devices) automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain omalizumab (rch) (other respiratory medicines and devices), including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - omalizumab (rch) (other respiratory medicines and devices)

Audience:
       

(Medicine)
02 Nov 2016 Xolair Vial (Powder for injection) (other respiratory medicines and devices) is a brand of medicine. Find out about side effects, who can and who shouldn’t use Xolair Vial (Powder for injection) (other respiratory medicines and devices) by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
(Medicine)
02 Nov 2016 Xolair Prefilled Syringe (Solution for injection) (other respiratory medicines and devices) is a brand of medicine. Find out about side effects, who can and who shouldn’t use Xolair Prefilled Syringe (Solution for injection) (other respiratory medicines and devices) by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
For health professionals (Health professional publication)
13 Aug 2014 Omalizumab is a PBS-listed treatment for some patients with immunoglobulin-E (IgE)-mediated sensitisation to inhalant allergens, which can be severe and difficult to treat.
(Medicine)
30 Apr 2014 Find out about the asthma medicines you may be prescribed if you are not achieving good asthma control, or if you are hospitalised with an asthma attack.

Medicine brands that contain omalizumab (rch) (other respiratory medicines and devices)